Thalys(SH:603716) Zheng Quan Shi Bao Wang·2025-07-01 09:48Core Viewpoint - The stock of Seli Medical (603716) reached its daily limit, with a turnover rate of 29.87% and a transaction volume of 892 million yuan, indicating significant trading activity and interest from investors [1][2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's "Dragon and Tiger List" due to its high turnover rate, with a net buying amount of 82.95 million yuan from brokerage seats [2]. - The top five brokerage seats accounted for a total transaction volume of 201 million yuan, with a buying amount of 142 million yuan and a selling amount of 59.24 million yuan, resulting in a net buying of 82.95 million yuan [2]. - The largest buying brokerage was Guotai Junan Securities, with a purchase amount of 38.21 million yuan, while the largest selling brokerage was Guoxin Securities, with a selling amount of 17.16 million yuan [2]. Historical Performance - Over the past six months, the stock has appeared on the Dragon and Tiger List 18 times, with an average price drop of 0.60% the day after being listed and an average decline of 0.31% over the following five days [3]. Capital Flow - The stock experienced a net inflow of 177 million yuan from major funds today, with a significant inflow of 176 million yuan from large orders [4]. - In the past five days, the net inflow of major funds totaled 198 million yuan [4]. Financial Performance - In the first quarter, the company reported a revenue of 287 million yuan, a year-on-year decrease of 40.75%, and a net loss of 14.32 million yuan [5].